To test whether ROS are responsible for the enhanced tumorigenic properties of NXPH4 in bladder cancer, we blocked the production of ROS with the antioxidant N-acetylcysteine (NAC). The gene discussed is NXPH4; the disease is urinary bladder carcinoma.